Healixia News - page 19

August 17, 2021

Unavailability of Visudyne 15 mg (powder for solution for infusion) : recommendations for (hospital) pharmacists and physicians-specialists

The medicinal product Visudyne 15 mg, used in ophthalmology, has been unavailable in Belgium since 30 May 2020. The FAMHP is therefore making recommendations.

Source: FAMHP

August 2, 2021

Call for applications to participate in the IFAPP working groups

With the election of a new Board of Officers (BoO) with new Standing Officers as Chairs of the Working Groups (WGs) we encourage you to apply for active membership in on of the following WGs:

July 20, 2021

Save the date: An EQ-5D-5L value set for Belgium – How to value health-related quality of life?

Source: KCE

Een Belgische waardenset voor de EQ-5D-5L – hoe gezondheidsgerelateerde levenskwaliteit waarderen?

Une matrice de valorisation belge pour l’EQ-5D-5L – Comment évaluer la qualité de vie liée à la santé ?

July 20, 2021

Coronavirus: biweekly review of updates to COVID-19 vaccines from 15 July 2021

Source: FAMHP

Coronavirus: tweewekelijks overzicht bijwerkingen COVID-19-vaccins van 15 juli 2021

Coronavirus : aperçu bimensuel des effets indésirables des vaccins contre la COVID-19 du 15 juillet 2021

July 20, 2021

First information session on the new Clinical Trial Regulation (CTR) on 23 September 2021

Source: FAMHP

The FAMHP is organising two information sessions on 23 September 2021 and 25 November 2021.

July 20, 2021

Discontinuation of the telephone contact point of the Marketing Authorisation Division (variations and renewals)

Source: FAMHP

The telephone contact point of the Marketing Authorisation Division (variations and renewals) will be discontinued as of Friday 16 July 2021. The division can still be contacted by email.

July 16, 2021

Coronavirus: take part in the scientific research on the coronavaccines because your experience makes vaccination even safer

Source: FAMHP

Coronavirus: neem deel aan het wetenschappelijk onderzoek over de coronavaccins want uw ervaring maakt vaccineren nog veiliger

Coronavirus : participez à l’étude scientifique sur les vaccins car votre expérience rend la vaccination encore plus sûre

July 16, 2021

Update on ongoing evaluation of COVID-19 vaccines

Source FAMHP

Update on ongoing evaluation of COVID-19 vaccines, EMA advises on COVID-19 Vaccine Janssen and no evidence linking gene therapy Zynteglo to blood cancer

July 12, 2021

Call for all sponsors to publish clinical trial results

Source FAMHP

The FAMHP reminds all sponsors they are obligated to publish the results of their clinical trials in the European Clinical Trials Database (EudraCT) within one year after the end of trial date (or six months for a paediatric trial).

July 12, 2021

The use of contraception after treatment with genotoxic medicines: add recommendations to patient information leaflets

Source FAMHP

The FAMHP reminds marketing authorisation holders of the obligation to add recommendations on the use of contraception to the package leaflet of genotoxic medicines.